CFTR and cystic fibrosis: We are confident that our efforts will allow us to enhance the understanding of the molecular and cellular mechanisms that are affected by the multiple defects that cause CF diseases, as well as to provide new information for the development of personalized combinations of CFTR modulators able to elicit a real clinical benefit for people with CF bearing class II and III mutations.